InvestorsHub Logo
Followers 164
Posts 36253
Boards Moderated 2
Alias Born 10/20/2019

Re: StockHighAlert- post# 34

Friday, 07/30/2021 1:05:32 PM

Friday, July 30, 2021 1:05:32 PM

Post# of 91
$KONEF has acquired 16 clinics across North America, with LOI’s signed for additional clinics. Its team is in the process of building the infrastructure needed to provide ketamine treatments through existing clinics, experienced professionals, and tech.

Ketamine One has made some really smart moves in a very short period of time. They essentially bought a turnkey business from Canabo, and have it set up that Canabo’s expertise won’t be wasted or forgotten moving forward. Their foray into tech reminds me of Cybin (CYBN.NE) approach with their partnership with Kernel. Ketamine One is headed in the right direction in terms of early stage revenue and profitability, and their other M&A activity shows that they are willing to think outside the box and not be just another generic psychedelics company.